Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-003164
Filing Date
2024-03-14
Accepted
2024-03-14 07:30:34
Documents
161
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 20-F aciu-20231231x20f.htm   iXBRL 20-F 4069532
2 EX-3.1 aciu-20231231xex3d1.htm EX-3.1 561170
3 EX-4.17 aciu-20231231xex4d17.htm EX-4.17 99106
4 EX-8.1 aciu-20231231xex8d1.htm EX-8.1 2996
5 EX-12.1 aciu-20231231xex12d1.htm EX-12.1 8927
6 EX-12.2 aciu-20231231xex12d2.htm EX-12.2 8978
7 EX-13.1 aciu-20231231xex13d1.htm EX-13.1 4392
8 EX-13.2 aciu-20231231xex13d2.htm EX-13.2 4870
9 EX-15.1 aciu-20231231xex15d1.htm EX-15.1 2557
10 EX-97.1 aciu-20231231xex97d1.htm EX-97.1 52795
11 GRAPHIC aciu-20231231x20f001.jpg GRAPHIC 117073
12 GRAPHIC aciu-20231231x20f002.jpg GRAPHIC 64879
13 GRAPHIC aciu-20231231x20f003.jpg GRAPHIC 60510
14 GRAPHIC aciu-20231231x20f004.jpg GRAPHIC 71486
15 GRAPHIC aciu-20231231x20f005.jpg GRAPHIC 85941
16 GRAPHIC aciu-20231231x20f006.jpg GRAPHIC 54345
17 GRAPHIC aciu-20231231x20f007.jpg GRAPHIC 64702
18 GRAPHIC aciu-20231231x20f008.jpg GRAPHIC 71905
19 GRAPHIC aciu-20231231x20f009.jpg GRAPHIC 70958
20 GRAPHIC aciu-20231231x20f010.jpg GRAPHIC 54084
21 GRAPHIC aciu-20231231x20f011.jpg GRAPHIC 60778
22 GRAPHIC aciu-20231231x20f012.jpg GRAPHIC 28926
23 GRAPHIC aciu-20231231x20f013.jpg GRAPHIC 58500
24 GRAPHIC aciu-20231231x20f014.jpg GRAPHIC 42600
25 GRAPHIC aciu-20231231x20f015.jpg GRAPHIC 50900
26 GRAPHIC aciu-20231231x20f016.jpg GRAPHIC 73129
27 GRAPHIC aciu-20231231x20f017.jpg GRAPHIC 28871
28 GRAPHIC aciu-20231231x20f018.jpg GRAPHIC 92793
29 GRAPHIC aciu-20231231x20f019.jpg GRAPHIC 85464
30 GRAPHIC aciu-20231231x20f020.jpg GRAPHIC 33064
31 GRAPHIC aciu-20231231x20f021.jpg GRAPHIC 29446
32 GRAPHIC aciu-20231231x20f022.jpg GRAPHIC 26986
33 GRAPHIC aciu-20231231x20f023.jpg GRAPHIC 34641
34 GRAPHIC aciu-20231231x20f024.jpg GRAPHIC 90108
35 GRAPHIC aciu-20231231x20f025.jpg GRAPHIC 34765
36 GRAPHIC aciu-20231231x20f026.jpg GRAPHIC 95756
37 GRAPHIC aciu-20231231x20f027.jpg GRAPHIC 30911
38 GRAPHIC aciu-20231231x20f028.jpg GRAPHIC 30999
39 GRAPHIC aciu-20231231x20f029.jpg GRAPHIC 25285
40 GRAPHIC aciu-20231231x20f030.jpg GRAPHIC 40655
41 GRAPHIC aciu-20231231x20f031.jpg GRAPHIC 68275
42 GRAPHIC aciu-20231231x20f032.jpg GRAPHIC 175460
  Complete submission text file 0001558370-24-003164.txt   20920851

Data Files

Seq Description Document Type Size
43 EX-101.SCH aciu-20231231.xsd EX-101.SCH 121860
44 EX-101.CAL aciu-20231231_cal.xml EX-101.CAL 69934
45 EX-101.DEF aciu-20231231_def.xml EX-101.DEF 368778
46 EX-101.LAB aciu-20231231_lab.xml EX-101.LAB 814506
47 EX-101.PRE aciu-20231231_pre.xml EX-101.PRE 657505
163 EXTRACTED XBRL INSTANCE DOCUMENT aciu-20231231x20f_htm.xml XML 3069185
Mailing Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000
Business Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000 41 21 345 91 21
AC Immune SA (Filer) CIK: 0001651625 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-37891 | Film No.: 24747925
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)